Cigna wins case to block Amy Bricker's move to CVS

AdobeCVSHealthviewedAmyBrickerasapotentialCEO.Butshewon’tbegoingtothehealthcareconglomerateanytimeso FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida




leisure time

author：fashion    Page View：1123
Adam's take main illustration
Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

advertisement

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： How faith leaders like me can help address America's obesity epidemic
Next article： Novavax promises a turnaround & Lilly roils the obesity market